Manic symptoms probably associated with short-term low-dose quetiapine use

Advances in Therapy

Volumn 25, Issue 1, 2008, Pages 53-58

  Erberk Ozen, Nurper ^a,b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Adverse effects; Hypomania; Mania; Psychiatry; Quetiapine; Schizophrenia

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; HALOPERIDOL; OLANZAPINE; QUETIAPINE; SULPIRIDE; ZUCLOPENTHIXOL; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELUSION; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; DYSKINESIA; ELECTROCONVULSIVE THERAPY; EUPHORIA; EXTRAPYRAMIDAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; IRRITABILITY; LOW DRUG DOSE; MALE; MANIA; MOOD DISORDER; MUSCLE RIGIDITY; PARANOID SCHIZOPHRENIA; PARKINSONISM; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; HUMANS; MALE; SCHIZOPHRENIA;

EID: 58749115771     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-008-0003-4     Document Type: Article

References (15)

1. Saller CF, Salama AI. Seroquel: Biochemical profile of a potential atypical antipsychotic. Psychopharmacol. 1993;112:285-292
2. Aubry JM, Simon AE, Bertschy G. Possible induction of mania and hypomania by olanzapine or risperidone: A critical review of reported cases. J Clin Psychiatry. 2000;61:649-655.
3. Michalopoulou PG, Lykouras L. Manic/hypomanic symptoms induced by atypical antipsychotics: A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:549-564.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision. (DSM IV-TR). 4th ed. Washington, DC: American Psychiatric Association; 2005.
5. Vieta E, Goikolea JM. Atypical antipsychotics: Newer options for mania and maintenance therapy. Bipolar Disord. 2005;7 (suppl 4):21-33.
6. Atmaca M, Kuloglu M, Buyukbayram A, et al. Quetiapine-associated and dose-related hypomania in a woman with schizophrenia. Eur Psychiatry. 2002;17:292-293.
7. Biancosino B, Marmai L, Facchi A, et al. Quetiapine may induce mania: A case report. Can J Psychiatry. 2003;48:349-350.
8. Rachid F, Bertschy G, Bondolfi G, et al. Possible induction of mania or hypomania by atypical antipsychotics: An update review of reported cases. J Clin Psychiatry. 2004;65:1537-1545.
9. Galynker I, Khan A, Grebchenko Y, et al. Low-dose risperidone and quetiapine as monotherapy for comorbid anxiety and depression [Letter]. J Clin Psychiatry. 2005;66:544.
10. Schutters SI, van Megen HJ, Westenberg HG. Efficacy of quetiapine in generalized social anxiety disorder: Results from an open label study. J Clin Psychiatry. 2005;66:540-542.
11. Gao K, Muzina D, Gajwani P, et al. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: A review. J Clin Psychiatry. 2006;67:1327-1340.
12. Post RM, Altshuler LL. Mood disorders: Treatment of bipolar disorders. In: Ie]Sadock BJ, Sadock VA, eds. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:1661-1707.
13. de Leon J, Susce MT, Pan RM, et al. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation. J Clin Psychiatry. 2005;66:15-27.
14. Strakowski SM, Keck PE Jr, Wong YM, et al. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders. J Clin Psychopharmacol. 2002;22:2001-2005.
15. Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.